PCPCX
Price
$5.22
Change
-$0.01 (-0.19%)
Updated
Jul 3 closing price
Net Assets
4.53B
RYMEX
Price
$153.80
Change
-$0.44 (-0.29%)
Updated
Jul 3 closing price
Net Assets
6.79M
Interact to see
Advertisement

PCPCX vs RYMEX

Header iconPCPCX vs RYMEX Comparison
Open Charts PCPCX vs RYMEXBanner chart's image
PIMCO CommoditiesPLUS® Strategy C
Price$5.22
Change-$0.01 (-0.19%)
VolumeN/A
Net Assets4.53B
Rydex Commodities Strategy A
Price$153.80
Change-$0.44 (-0.29%)
VolumeN/A
Net Assets6.79M
PCPCX vs RYMEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PCPCX vs. RYMEX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCPCX is a Hold and RYMEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PCPCX has more cash in the bank: 4.53B vs. RYMEX (6.79M). PCPCX pays higher dividends than RYMEX: PCPCX (7.52) vs RYMEX (0.00). PCPCX was incepted earlier than RYMEX: PCPCX (15 years) vs RYMEX (20 years). PCPCX (2.20) is less costly to investors than RYMEX (1.89). PCPCX has a lower initial minimum investment than RYMEX: PCPCX (1000) vs RYMEX (2500). RYMEX annual gain was more profitable for investors over the last year : -1.25 vs. PCPCX (-2.02). PCPCX return over 5 years is better than : 124.53 vs. RYMEX (-9.80).
PCPCXRYMEXPCPCX / RYMEX
Total Expense Ratio2.031.66122%
Annual Report Gross Expense Ratio2.201.89116%
Fund Existence15 years20 years-
Gain YTD1.5262.26167%
Front LoadN/A5%-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/A1000-
Net Assets4.53B6.79M66,672%
Annual Yield % from dividends7.520.00-
Returns for 1 year-2.02-1.25161%
Returns for 3 years2.44-20.29-12%
Returns for 5 years124.53-9.80-1,270%
Returns for 10 years64.77-65.01-100%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCBG41.341.06
+2.63%
Capital City Bank Group
FFIV300.134.01
+1.35%
F5, Inc.
VICR46.270.42
+0.92%
Vicor Corp
QNCX1.610.01
+0.62%
Quince Therapeutics
FOXO0.17N/A
-1.69%
FOXO Technologies Inc